People · Operator
Named in public records as an officer, director or promoter · active 2021–2024 · Biotechnology
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| Attralus, Inc. | — | Biotechnology | Series D+ | $172.8M | $709.1M | 2021 |
Nancy Miller-Rich at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside Nancy Miller-Rich on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| Corey Goodman | 1 | 13 |
| Richard Gaster | 1 | 7 |
| Mehdi Khodadad | 1 | 3 |
| Rahul Kakkar | 1 | 3 |
| Greg Bell | 1 | 2 |
| Jonathan Wall | 1 | 2 |
| Gregory Bell | 1 | 2 |
| Jake Bauer | 1 | 2 |
| Glen Firestone | 1 | 1 |
| Spencer Guthrie | 1 | 1 |
| James Testa | 1 | 1 |
| Alex Denner | 1 | 1 |
| Benson Fong | 1 | 1 |
| Mark Timney | 1 | 1 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.